# OnCo record paper-elara-tisagenlecleucel-follicular-nat-med-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-elara-tisagenlecleucel-follicular-nat-med-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-elara-tisagenlecleucel-follicular-nat-med-2022" ;
  schema:name "Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial"@en ;
  schema:alternateName "ELARA"@en, "Fowler 2022"@en ;
  schema:description "A single infusion of reprogrammed immune cells cleared follicular lymphoma completely in about seven of ten heavily pretreated people, with no severe cytokine release syndrome at all."@en ;
  schema:url <https://onco.cc/key-papers/paper-elara-tisagenlecleucel-follicular-nat-med-2022/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-021-01622-0>, <https://pubmed.ncbi.nlm.nih.gov/34921238/>, <https://europepmc.org/article/MED/34921238> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1038/s41591-021-01622-0> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Fowler NH, Dickinson M, Dreyling M, et al." ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/tisagenlecleucel/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:terms <https://onco.cc/terms/crs/>, <https://onco.cc/terms/icans/>, <https://onco.cc/terms/complete-response/>, <https://onco.cc/terms/lymphoma-tx-pod24/> ;
  onco:trials <https://onco.cc/trials/elara/>, <https://onco.cc/trials/zuma-5/> ;
  onco:people <https://onco.cc/people/catherine-thieblemont/>, <https://onco.cc/people/martin-dreyling/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-manufacturing-cell-therapy/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:journals <https://onco.cc/journals/nature-medicine/> .